Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Prosensa Holding BV

Division of BioMarin Pharmaceutical Inc.
www.prosensa.eu

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Prosensa BV
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • BioMarin Pharmaceutical Inc.
  • Senior Management
  • Hans Schikan, CEO
    Berndt Modig, CFO
    Luc Dochez, CBO and SVP, Bus. Dev.
    Giles Campion, MD, CMO and SVP, R&D
    Willem W van Weperen, Chief Commercial Officer
  • Contact Info
  • Prosensa Holding BV
    Phone: (31) 71 3322100
    J.H. Oortweg 21
    Leiden, 2333 CH
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register